Are Emerging MET Inhibitors Meeting Expectations in Lung Cancer?

Cancer Network spoke with Karen L. Reckamp, MD, medical oncologist at City of Hope, about trial data presented at ASCO 2019 on emerging MET inhibitors for the treatment of lung cancer, as well as whether these options are meeting expectations. Dr. Reckamp was a discussant at an educational session at ASCO entitled, "New Drugs and Resistance: Have We MET Expectations?"